Repetitive Transcranial Magnetic Stimulation (rTMS)
Conditions
Brief summary
The purpose of this study is to investigate how repetitive transcranial magnetic stimulation (rTMS) affects brain networks measured by functional magnetic resonance imaging (fMRI). Participants will undergo a screening that includes a psychiatric and medical history screening, TMS and MRI safety screening, and urine screening. If participants pass the screening procedure, they will be introduced to transcranial magnetic stimulation (TMS), magnetic resonance imaging (MRI), and a task that involves viewing words, sentences, or pictures. There will be up to seven visits and each visit will take less than 3 hours. MRI can be dangerous for people that have medical devices, metal objects, or metal debris in their bodies. TMS procedures are associated with a very low risk of seizures, muscle-tension type headache, ear damage, numbness of the face, fainting, dizziness, memory impairment, trouble concentrating, and acute mood changes. This study will use only levels of TMS that are within safety guidelines. There is also a risk of potential loss of confidentiality.
Interventions
DEVICErTMS
TMS will be applied over task-based target at an intensity up of 130% rMT. The optimal coil placement during stimulation will be guided using the BrainSight neuronavigation system.
DEVICESham rTMS
An electrical sham coil that produces the same auditory and somatosensory stimulations, without a significant magnetic field, will be used as an active control.
PROCEDUREMRI scan
Participants will undergo an MRI scan directly after rTMS stimulation that will last less than 120 minutes. During the scan, subjects will encode and retrieve object pictures.
Sponsors
Duke University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes
Inclusion criteria
* Age restrictions: between 18-35 years old * Use of effective method of birth control for women of childbearing capacity. * Willing to provide informed consent.
Exclusion criteria
* Current or recent (within the past 6 months) substance abuse or dependence, excluding nicotine and caffeine (urine test) * Current serious medical illness (self-report) * History of seizure except those therapeutically induced by ECT (childhood febrile seizures are acceptable and these subjects may be included in the study), history of epilepsy in self or first degree relatives, stroke, brain surgery, head injury, cranial metal implants, known structural brain lesion, devices that may be affected by rTMS or MRI (pacemaker, medication pump, cochlear implant, implanted brain stimulator) * Subjects are unable or unwilling to give informed consent * Diagnosed any Axis I DSM-IV disorder (MINI, DSM-IV) Subjects with a clinically defined neurological disorder including, but not limited to: * Any condition likely to be associated with increased intracranial pressure * Space occupying brain lesion. * History of stroke. * Transient ischemic attack within two years. * Cerebral aneurysm. * Dementia. * Parkinson's disease. * Huntington's disease. * Multiple sclerosis. * Increased risk of seizure for any reason, including prior diagnosis of increased intracranial pressure (such as after large infarctions or trauma), or currently taking medication that lowers the seizure threshold * Subjects with cochlear implants * Subjects not willing to tolerate the confinement associated with being in the MRI scanner * Women who are pregnant or breast-feeding (urine test)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of a rTMS session on the performance for a memory task, as measured by accuracy (in percentage of correct responses) | up to 1 month |
| An effect of a rTMS session on the performance for a memory task, as measured by reaction time (in ms) | Time frame: up to 1 month |
| An effect of a rTMS session on fMRI brain representation for a memory task, as measured by BOLD signal | up to 1 month |
Countries
United States
Outcome results
None listed